Andlauer Healthcare Group (TSE:AND) has released an update.
Andlauer Healthcare Group reported a modest revenue increase of 1.8% to $159.6 million for Q3 2024, supported by strong performance in logistics and Canadian transportation sectors. Despite challenges in U.S. truckload operations, net income rose to $16.3 million, with an improved EBITDA margin of 25.9%. The company remains well-positioned for acquisitions with a robust balance sheet as interest rates ease.
For further insights into TSE:AND stock, check out TipRanks’ Stock Analysis page.
